awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34429203-79521BD2-B8C9-41DC-AFAD-E92B60ADAA3E
Q34429203-79521BD2-B8C9-41DC-AFAD-E92B60ADAA3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34429203-79521BD2-B8C9-41DC-AFAD-E92B60ADAA3E
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
P932
Q34429203-79521BD2-B8C9-41DC-AFAD-E92B60ADAA3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34429203-79521BD2-B8C9-41DC-AFAD-E92B60ADAA3E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94ccea54e9d249f59e3b7d50ed56443a3bc16bbc
P932
3447808
http://www.w3.org/2001/XMLSchema#string